- Home
- CMPS vs LAZR Comparison
CMPS vs LAZR Comparison
Compare CMPS & LAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- LAZR
- Stock Information
- Founded
- CMPS 2020
- LAZR 2012
- Country
- CMPS United Kingdom
- LAZR United States
- Employees
- CMPS N/A
- LAZR N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- LAZR Auto Parts:O.E.M.
- Sector
- CMPS Health Care
- LAZR Consumer Discretionary
- Exchange
- CMPS Nasdaq
- LAZR Nasdaq
- Market Cap
- CMPS 364.9M
- LAZR 140.7M
- IPO Year
- CMPS 2020
- LAZR N/A
- Fundamental
- Price
- CMPS $3.56
- LAZR $2.87
- Analyst Decision
- CMPS Strong Buy
- LAZR Hold
- Analyst Count
- CMPS 7
- LAZR 7
- Target Price
- CMPS $17.83
- LAZR $37.83
- AVG Volume (30 Days)
- CMPS 5.0M
- LAZR 2.7M
- Earning Date
- CMPS 07-31-2025
- LAZR 08-12-2025
- Dividend Yield
- CMPS N/A
- LAZR N/A
- EPS Growth
- CMPS N/A
- LAZR N/A
- EPS
- CMPS N/A
- LAZR N/A
- Revenue
- CMPS N/A
- LAZR $73,313,000.00
- Revenue This Year
- CMPS N/A
- LAZR $16.78
- Revenue Next Year
- CMPS N/A
- LAZR $29.92
- P/E Ratio
- CMPS N/A
- LAZR N/A
- Revenue Growth
- CMPS N/A
- LAZR N/A
- 52 Week Low
- CMPS $2.25
- LAZR $2.52
- 52 Week High
- CMPS $8.54
- LAZR $32.70
- Technical
- Relative Strength Index (RSI)
- CMPS 48.54
- LAZR 42.35
- Support Level
- CMPS $3.45
- LAZR $2.69
- Resistance Level
- CMPS $3.88
- LAZR $3.14
- Average True Range (ATR)
- CMPS 0.26
- LAZR 0.16
- MACD
- CMPS 0.07
- LAZR 0.04
- Stochastic Oscillator
- CMPS 77.29
- LAZR 35.44
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.